Haschke M - Search Results

1

Interactions of the hepatitis C virus protease inhibitor faldaprevir with cytochrome P450 enzymes: in vitro and in vivo correlation.

Sabo JP, Kort J, Ballow C, Kashuba AD, Haschke M, Battegay M, Girlich B, Ting N, Lang B, Zhang W, Cooper C, O'Brien D, Seibert E, Chan TS, Tweedie D, Li Y. Sabo JP, et al. Among authors: haschke m. J Clin Pharmacol. 2015 Apr;55(4):467-77. doi: 10.1002/jcph.436. Epub 2015 Jan 14. J Clin Pharmacol. 2015. PMID: 25449227 Clinical Trial.

2

Clinical assessment of potential drug interactions of faldaprevir, a hepatitis C virus protease inhibitor, with darunavir/ritonavir, efavirenz, and tenofovir.

Sabo JP, Kort J, Ballow C, Haschke M, Battegay M, Fuhr R, Girlich B, Schobelock M, Feifel U, Lang B, Li Y, Elgadi M. Sabo JP, et al. Among authors: haschke m. Clin Infect Dis. 2014 Nov 15;59(10):1420-8. doi: 10.1093/cid/ciu616. Epub 2014 Aug 4. Clin Infect Dis. 2014. PMID: 25091302 Clinical Trial.

3

Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2.

Bachmann F, Duthaler U, Meyer Zu Schwabedissen HE, Puchkov M, Huwyler J, Haschke M, Krähenbühl S. Bachmann F, et al. Among authors: haschke m. Clin Pharmacol Ther. 2021 Jun;109(6):1505-1516. doi: 10.1002/cpt.2141. Epub 2021 Jan 19. Clin Pharmacol Ther. 2021. PMID: 33336382 Free PMC article.

4

Pharmacokinetics of intravenous and oral midazolam in plasma and saliva in humans: usefulness of saliva as matrix for CYP3A phenotyping.

Link B, Haschke M, Grignaschi N, Bodmer M, Aschmann YZ, Wenk M, Krähenbühl S. Link B, et al. Among authors: haschke m. Br J Clin Pharmacol. 2008 Oct;66(4):473-84. doi: 10.1111/j.1365-2125.2008.03201.x. Epub 2008 Apr 11. Br J Clin Pharmacol. 2008. PMID: 18537963 Free PMC article. Clinical Trial.

5

Food effect and biocomparison of two formulations of the dual orexin receptor antagonist almorexant in healthy male subjects.

Hoch M, Hoever P, Haschke M, Krähenbühl S, Dingemanse J. Hoch M, et al. Among authors: haschke m. J Clin Pharmacol. 2011 Jul;51(7):1116-21. doi: 10.1177/0091270010377634. Epub 2010 Sep 17. J Clin Pharmacol. 2011. PMID: 20852003 Clinical Trial. No abstract available.

6

Intranasal midazolam: pharmacokinetics and pharmacodynamics assessed by quantitative EEG in healthy volunteers.

Hardmeier M, Zimmermann R, Rüegg S, Pflüger M, Deuster S, Suter K, Donzelli M, Drewe J, Krähenbühl S, Fuhr P, Haschke M. Hardmeier M, et al. Among authors: haschke m. Clin Pharmacol Ther. 2012 May;91(5):856-62. doi: 10.1038/clpt.2011.316. Epub 2012 Mar 28. Clin Pharmacol Ther. 2012. PMID: 22453191 Clinical Trial.

7

Effects of Cytochrome P450 Inhibition and Induction on the Phenotyping Metrics of the Basel Cocktail: A Randomized Crossover Study.

Derungs A, Donzelli M, Berger B, Noppen C, Krähenbühl S, Haschke M. Derungs A, et al. Among authors: haschke m. Clin Pharmacokinet. 2016 Jan;55(1):79-91. doi: 10.1007/s40262-015-0294-y. Clin Pharmacokinet. 2016. PMID: 26123704 Free PMC article. Clinical Trial.

8

Reduction of hyperbilirubinemia with hypericum extract (St. John's Wort) in a patient with Crigler-Najjar syndrome type II.

Kummer O, Hammann F, Haschke M, Krähenbühl S. Kummer O, et al. Among authors: haschke m. Br J Clin Pharmacol. 2016 May;81(5):1002-4. doi: 10.1111/bcp.12869. Epub 2016 Mar 7. Br J Clin Pharmacol. 2016. PMID: 26692114 Free PMC article.

9

Role of Cytochrome P450 3A4 and 1A2 Phenotyping in Patients with Advanced Non-small-Cell Lung Cancer Receiving Erlotinib Treatment.

Parra-Guillen ZP, Berger PB, Haschke M, Donzelli M, Winogradova D, Pfister B, Früh M, Gillessen S, Krähenbühl S, Kloft C, Joerger M. Parra-Guillen ZP, et al. Among authors: haschke m. Basic Clin Pharmacol Toxicol. 2017 Oct;121(4):309-315. doi: 10.1111/bcpt.12801. Epub 2017 Jun 19. Basic Clin Pharmacol Toxicol. 2017. PMID: 28444958 Free article. Clinical Trial.

10

Pharmacokinetics and phenotyping properties of the Basel phenotyping cocktail combination capsule in healthy male adults.

Suenderhauf C, Berger B, Puchkov M, Schmid Y, Müller S, Huwyler J, Haschke M, Krähenbühl S, Duthaler U. Suenderhauf C, et al. Among authors: haschke m. Br J Clin Pharmacol. 2020 Feb;86(2):352-361. doi: 10.1111/bcp.14157. Epub 2019 Dec 12. Br J Clin Pharmacol. 2020. PMID: 31657866 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters